{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:34:02Z","timestamp":1794555242398,"version":"4.9.1"},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":3495,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[1996,10]]},"abstract":"<jats:p>Retinoids are potent cell growth and differentiation modulators, but cellular effects of therapeutic retinoids in psoriasis are unknown. We studied the effects of etretinate on pathological activation of keratinocytes and lymphocytes in patients treated systemically with this agent for 8 weeks. Ten patients with extensive psoriasis vulgaris were treated with etretinate at 0.75 mg\/kg for 8 weeks. Skin biopsies obtained before and at 8 weeks of treatment were studied using immunohistochemical markers for keratinocyte proliferation or differentiation and for the presence of T\u2010lymphocyte subsets or associated inflammatory proteins. During 8 weeks of treatment, the clinical severity decreased by a mean of 64% (p &lt; 0.001). Compared to a similar group of patients treated with bath PUVA, psoriatic plaque erythema resolved more slowly and less completely (p &lt; 0.05), but improvements in plaque thickness and scale were not significantly different between etretinate and PUVA treatments. Etretinate produced a 44% decrease in epidermal thickness (p &lt; 0.001) and a 62% reduction in keratinocyte proliferation (p &lt; 0.001) after 8 weeks of treatment. Unexpectedly, keratinocyte differentiation was enhanced following etretinate treatment as indicated by increased filaggrin production, increased number and size of keratohyaline granules, greater abundance of keratin filaments, and increased secretion of intercellular lipids from Odland bodies. The stratum corneum in resolving psoriatic lesions was unusually thin, probably caused by retinoid\u2010induced shedding of corneocytes. \u201cRegenerative\u201d epidermal growth was maintained during etretinate treatment, as marked by continued expression of keratin 16 and a3\u2010integrin by suprabasal keratinocytes. Surprisingly, the inflammation\u2010associated proteins HLA\u2010DR and ICAM\u20101 were no longer produced by epidermal keratinocytes following etretinate treatment, and CD3+, CD8+, and CD25+ T\u2010lymphocyte subsets were reduced by 50\u201065% in lesional tissue (p &lt; 0.01). Etretinate shows unexpected anti\u2010inflammatory and pro\u2010differentiation actions in psoriasis. Etretinate appears to function as a disease suppressive agent which improves hyperplasia, keratinocyte differentiation and tissue inflammation mediated by cellular immune elements.<\/jats:p>","DOI":"10.1111\/j.1600-0560.1996.tb01430.x","type":"journal-article","created":{"date-parts":[[2006,4,29]],"date-time":"2006-04-29T10:55:09Z","timestamp":1146308109000},"page":"404-418","source":"Crossref","is-referenced-by-count":45,"title":["Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell\u2010mediated inflammation are unexpected outcomes"],"prefix":"10.1111","volume":"23","author":[{"given":"Scott L.","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gilleaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"151","volume-title":"Psoriasis","author":"Rosenbach T","year":"1994"},{"key":"e_1_2_1_3_2","first-page":"63","volume-title":"Psoriasis","author":"Gottlieb AB","year":"1994"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0595-442"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00372065"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240315"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117659"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.283"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.6.2057"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499782"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12471216"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12470632"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00372073"},{"key":"e_1_2_1_14_2","first-page":"521","volume-title":"The retinoids: biology, chemistry, and medicine","author":"Ross AC","year":"1994"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.48.5.444"},{"key":"e_1_2_1_16_2","first-page":"459","article-title":"Effects of systemic etretinate treatment on natural cytotoxicity, immune angiogenesis and neutrophil adherence in patients with various forms of psoriasis","volume":"37","author":"Majewski S","year":"1989","journal-title":"Arch Immunol Ther Exp"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000250023"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70198-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/33.8.4020099"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12491525"},{"key":"e_1_2_1_21_2","first-page":"39","volume-title":"Therapy of moderate\u2010to\u2010severe psoriasis","author":"Vallat VP","year":"1993"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00424268"},{"key":"e_1_2_1_23_2","unstructured":"WolfeJ NabeyaR VallatVP.et al.Is psoriasis primarily a disorder of epidermal CD4\/CD8 T lymphocytes and epidermal regenerative activationJ Invest Dermatol1993: (Abstract)."},{"key":"e_1_2_1_24_2","unstructured":"LuI.GilleaudeauP McLaneJA et al.Modulation of epidermal differentiation tissue inflammation and T\u2010lymphocyte infiltration in psoriatic plaques by topical calcitriol.J Am Acad Dermatol1995(submitted)."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680050115015"},{"key":"e_1_2_1_26_2","first-page":"18","volume-title":"Psoriasis","author":"Krueger JG","year":"1994"},{"key":"e_1_2_1_27_2","first-page":"1","volume-title":"Therapy of moderate\u2010to\u2010severe psoriasis","author":"Weinstein CD","year":"1993"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499901"},{"key":"e_1_2_1_29_2","first-page":"181","volume-title":"Molecular biology of the skin. The Keratinocyte","author":"Darmon M","year":"1993"},{"key":"e_1_2_1_30_2","first-page":"631","volume-title":"The retinoids: biology, chemistry, and medicine","author":"Peck GL","year":"1994"},{"key":"e_1_2_1_31_2","first-page":"84","volume-title":"Pharmacology of retinoids in the skin","author":"Regnier M","year":"1989"},{"key":"e_1_2_1_32_2","first-page":"1","volume-title":"Pharmacology of retinoids in the skin","author":"Roop DR","year":"1989"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600830505"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12479191"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12465404"},{"key":"e_1_2_1_36_2","first-page":"198","volume-title":"Therapeutic approaches 10 inflammatory diseases","author":"Woodworth TG","year":"1989"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9282"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.121.7.877"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12522564"},{"issue":"25","key":"e_1_2_1_40_2","first-page":"55","article-title":"Evidence for anti\u2010inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience","volume":"109","author":"Orfanos CE","year":"1983","journal-title":"Br J Dermatol"},{"key":"e_1_2_1_41_2","first-page":"1389","article-title":"Neutrophil functions in vivo on human skin. Psoriasis and anti\u2010inflammatory drug studies","volume":"35","author":"Dubertret L","year":"1987","journal-title":"Pathologic Biologie"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248865"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.1996.tb01430.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0560.1996.tb01430.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T19:08:41Z","timestamp":1698433721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.1996.tb01430.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["10.1111\/j.1600-0560.1996.tb01430.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.1996.tb01430.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}